BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3439980)

  • 1. [Use of the CS-3000 Cell Separator (Fenwal) for therapeutic lymphocyte depletion in thrombocytopenic patients with chronic lymphatic leukemia (CLL)].
    Brauer H; Aulmann HM; Wassmann A; Stangel W; Le Blanc S; Diedrich H; Meinicke K; Poliwoda H
    Beitr Infusionther Klin Ernahr; 1987; 18():230-3. PubMed ID: 3439980
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic cytapheresis using the Fenwal CS-3000 blood cell separator.
    Steeper TA; Smith JA; McCullough J
    Vox Sang; 1985; 48(4):193-200. PubMed ID: 3984305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donors leukapheresis on Fenwal CS-3000.
    Kotelba-Witkowska B; Mrowiec ZR; Daszyński J; Skrzeczkowska E
    Mater Med Pol; 1990; 22(1):33-5. PubMed ID: 2079859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive leukapheresis in the management of cytopenias in patients with chronic lymphocytic leukaemia (CLL) and lymphocytic lymphoma.
    Cooper IA; Ding JC; Adams PB; Quinn MA; Brettell M
    Am J Hematol; 1979; 6(4):387-98. PubMed ID: 316970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic lymphapheresis in leukostasis-induced priapism].
    Strobel E; Howe J; Bäcker U; Ernst G; Mempel M
    Dtsch Med Wochenschr; 1987 Dec; 112(51-52):1984-5. PubMed ID: 3691330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukapheresis: increasing the granulocyte yield with the Fenwal CS-3000.
    Loftus TJ; White RF; Huestis DW
    J Clin Apher; 1983; 1(2):109-14. PubMed ID: 6681481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic leukapheresis in a patient with prolymphocytic transformation of B-cell chronic lymphocytic leukemia.
    Steenssens L; Van Camp B
    Int J Artif Organs; 1984 May; 7(3):139-42. PubMed ID: 6610651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of the cell separator in the treatment of leukemia].
    Höcker P; Pittermann E; Gobets M; Pawlowsky J; Flegel U; Stacher A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(3):283-94. PubMed ID: 52575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Discontinuous cell separation as depletion therapy in chronic leukemias].
    Graubner M; Waldschmidt R; Kretschmer V; Mueller-Eckhardt C; Löffler H
    Onkologie; 1981 Jun; 4(3):162-7. PubMed ID: 7022292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation of therapeutic doses of leukocytes and thrombocytes using a blood cell separator].
    Bláha M; Vanasek J; Malý J; Siroký O; Pecka M
    Gematol Transfuziol; 1983 Oct; 28(10):23-5. PubMed ID: 6654008
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous-flow leukapheresis for rapid cytoreduction in leukemia.
    Lane TA
    Transfusion; 1980; 20(4):455-7. PubMed ID: 6931450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of long-term leukapheresis in the treatment of adult T-cell leukemia.
    Yamauchi K; Noguchi K; Shimizu M; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1982 Nov; 7(6):655-60. PubMed ID: 6985175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kinetics of the lymphocytes of patients with chronic lymphatic leukemia following lymphocytopheresis].
    Guseĭnov TN; Kotel'nikov VM; Dul'tsina SM; Kalinin NN; Polianskaia AM
    Probl Gematol Pereliv Krovi; 1982 Jul; 27(7):43-6. PubMed ID: 7122456
    [No Abstract]   [Full Text] [Related]  

  • 14. Depletion lymphocytapheresis in chronic lymphocytic leukemias: criteria for predicting which patients will respond to treatment.
    Rossi PL; Alfano G; D'Onofrio G; Menichella G; Mango G
    Int J Artif Organs; 1986 Jan; 9(1):59-62. PubMed ID: 3957456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities and results of the use of a cell separator in hematology].
    Stacher VA; HOCKER P; Pittermann E
    Wien Med Wochenschr; 1975 Jan; 125(1-3):35-44. PubMed ID: 236623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombocytopenia in chronic lymphocytic leukemia. Therapeutic results].
    Evensen SA; Stavem P; Carlsen E; Blichfeldt P; Mølstad P
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1395-6. PubMed ID: 6623446
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of platelet and leukocyte content in platelet concentrates obtained from CS-3000 and third generation (CS-3000 plus and Cobe-Spectra) cell separators].
    Dzieciatkowska A; Fuksiewicz M; Lachert E; Ziemba-Zółtowska B; Letowska M
    Acta Haematol Pol; 1995; 26(3):285-9. PubMed ID: 8525774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic progenitor cell large volume leukapheresis (LVL) on the Fenwal Amicus blood separator.
    Burgstaler EA; Pineda AA; Winters JL
    J Clin Apher; 2004; 19(2):103-11. PubMed ID: 15274204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and use of thrombocyte and leukocyte concentrates].
    Kalinin NN
    Probl Gematol Pereliv Krovi; 1980 Oct; 25(10):50. PubMed ID: 6999495
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombocyte aggregate formation during thrombocyte concentrate preparation with the CS-3000 Cell Separator (Fenwal) and its effects on the analysis of the concentrate with the Coulter Counter S Plus IV].
    Wassmann A; Aulmann HM; Stangel W; Meinicke K
    Beitr Infusionther Klin Ernahr; 1987; 18():216-8. PubMed ID: 3439976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.